Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.

PMID:
24743512
2.

Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.

Tai SK, Yang MH, Chang SY, Chang YC, Li WY, Tsai TL, Wang YF, Chu PY, Hsieh SL.

Cancer Sci. 2011 Apr;102(4):895-902. doi: 10.1111/j.1349-7006.2011.01859.x. Epub 2011 Mar 4.

3.

miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.

Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, Lin SC, Chang KW.

Int J Cancer. 2014 Feb 15;134(4):811-21. doi: 10.1002/ijc.28358. Epub 2013 Oct 8.

4.

microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.

Obayashi M, Yoshida M, Tsunematsu T, Ogawa I, Sasahira T, Kuniyasu H, Imoto I, Abiko Y, Xu D, Fukunaga S, Tahara H, Kudo Y, Nagao T, Takata T.

Oncotarget. 2016 Feb 16;7(7):8223-39. doi: 10.18632/oncotarget.6972.

5.

Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Wang L, Feng Z, Wu H, Zhang S, Pu Y, Bian H, Wang Y, Guo C.

Tumour Biol. 2014 Nov;35(11):10977-85. doi: 10.1007/s13277-014-2392-0. Epub 2014 Aug 5.

PMID:
25091574
6.

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.

Göke F, Bode M, Franzen A, Kirsten R, Goltz D, Göke A, Sharma R, Boehm D, Vogel W, Wagner P, Lengerke C, Kristiansen G, Kirfel J, Van Bremen T, Bootz F, Heasley LE, Schröck A, Perner S.

Mod Pathol. 2013 Oct;26(10):1298-306. doi: 10.1038/modpathol.2013.58. Epub 2013 Apr 26.

7.

Downregulation of leucine‑rich‑α‑2‑glycoprotein 1 expression is associated with the tumorigenesis of head and neck squamous cell carcinoma.

Wang Y, Chen C, Hua Q, Wang L, Li F, Li M, Mei Z, Zhou T, Xiao B, Tao Z.

Oncol Rep. 2017 Mar;37(3):1503-1510. doi: 10.3892/or.2017.5377. Epub 2017 Jan 17.

PMID:
28098902
8.

Involvement of CD74 in head and neck squamous cell carcinomas.

Kindt N, Lechien JR, Nonclercq D, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2014 Jun;140(6):937-47. doi: 10.1007/s00432-014-1648-9. Epub 2014 Mar 25.

PMID:
24663824
10.

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.

Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, Fend F, Staebler A, Bass AJ, Meyerson M, Rubin MA, Soltermann A, Lengerke C, Perner S.

Mod Pathol. 2011 Jul;24(7):944-53. doi: 10.1038/modpathol.2011.49. Epub 2011 Apr 1.

11.

TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.

Ozawa D, Yokobori T, Sohda M, Sakai M, Hara K, Honjo H, Kato H, Miyazaki T, Kuwano H.

Ann Surg Oncol. 2016 Jan;23(1):282-9. doi: 10.1245/s10434-014-4259-4. Epub 2014 Dec 2.

PMID:
25448803
12.

HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.

de Barros E Lima Bueno R, Ramão A, Pinheiro DG, Alves CP, Kannen V, Jungbluth AA, de Araújo LF, Muys BR, Fonseca AS, Plaça JR, Panepucci RA, Neder L, Saggioro FP, Mamede RC, Figueiredo DL, Silva WA Jr.

Tumour Biol. 2016 Nov;37(11):15087-15096. Epub 2016 Sep 22.

PMID:
27658780
13.

Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.

Song B, Cui H, Li Y, Cheng C, Yang B, Wang F, Kong P, Li H, Zhang L, Jia Z, Bi Y, Wang J, Zhou Y, Liu J, Wang J, Zhao Z, Zhang Y, Hu X, Shi R, Yang J, Liu H, Yan T, Li Y, Xu E, Qian Y, Xi Y, Guo S, Chen Y, Wang J, Li G, Liang J, Jia J, Chen X, Guo J, Wang T, Zhang Y, Li Q, Wang C, Cheng X, Zhan Q, Cui Y.

Oncotarget. 2016 Jan 19;7(3):3599-613. doi: 10.18632/oncotarget.6120.

14.

Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.

Schröck A, Göke F, Wagner P, Bode M, Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S.

PLoS One. 2013;8(3):e59201. doi: 10.1371/journal.pone.0059201. Epub 2013 Mar 27.

15.

PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.

Ni S, Chen L, Li M, Zhao W, Shan X, Wu M, Cheng J, Liang L, Wang Y, Jiang W, Zhang J, Ni R.

Tumour Biol. 2016 Oct;37(10):13799-13809. Epub 2016 Aug 1.

PMID:
27481515
16.

Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.

Bayo P, Jou A, Stenzinger A, Shao C, Gross M, Jensen A, Grabe N, Mende CH, Rados PV, Debus J, Weichert W, Plinkert PK, Lichter P, Freier K, Hess J.

Mol Oncol. 2015 Oct;9(8):1704-19. doi: 10.1016/j.molonc.2015.05.006. Epub 2015 May 20.

17.

Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.

Chang X, Zhang J, Huang C, Pang X, Luo Q, Zhang H, Zhang S.

Tumour Biol. 2015 Sep;36(10):7725-33. doi: 10.1007/s13277-015-3450-y. Epub 2015 May 3.

PMID:
25935536
18.

Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.

PMID:
20593490
19.

A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.

Wakasaki T, Masuda M, Niiro H, Jabbarzadeh-Tabrizi S, Noda K, Taniyama T, Komune S, Akashi K.

Neoplasia. 2010 Oct;12(10):789-96.

20.

PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.

Zhang JX, Tong ZT, Yang L, Wang F, Chai HP, Zhang F, Xie MR, Zhang AL, Wu LM, Hong H, Yin L, Wang H, Wang HY, Zhao Y.

Int J Cancer. 2013 Jun 1;132(11):2567-77. doi: 10.1002/ijc.27930. Epub 2012 Nov 26.

Supplemental Content

Support Center